| Insideraktier | 32.944.839 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Inozyme Pharma, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i INZY / Inozyme Pharma, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i INZY / Inozyme Pharma, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-01 | 4 | Subramanian Sanjay | INZY | Common Stock | D | 4,0000 | -39.701 | -159 | 0 | ||||
| 2025-07-03 | 2025-07-01 | 4 | Winton Matthew | INZY | Common Stock | D | 4,0000 | -21.743 | -87 | 0 | ||||
| 2025-07-03 | 2025-07-01 | 4 | Bolte Axel | INZY | Common Stock | D | 4,0000 | -423.926 | -1.696 | 0 | ||||
| 2025-07-03 | 2025-07-01 | 4 | Treco Douglas A | INZY | Common Stock | D | 4,0000 | -43.861 | -175 | 0 | ||||
| 2025-07-03 | 2025-07-01 | 4 | Hopfner Robert Lorne By Pivotal | INZY | Common Stock | I | 4,0000 | -1.571.741 | -6.287 | 0 | ||||
| 2025-07-03 | 2025-07-01 | 4 | Hopfner Robert Lorne By Pivotal | INZY | Common Stock | I | 4,0000 | -2.923.110 | -11.692 | 0 | ||||
| 2025-06-27 | 2025-06-25 | 4 | Subramanian Sanjay | INZY | Common Stock | D | 0,7400 | 6.813 | 5 | 39.701 | ||||
| 2025-06-27 | 2025-06-25 | 4 | Treco Douglas A | INZY | Common Stock | D | 0,7400 | 2.815 | 2 | 43.861 | ||||
| 2025-06-27 | 2025-06-25 | 4 | Winton Matthew | INZY | Common Stock | D | 0,7400 | 14.355 | 11 | 21.743 | ||||
| 2025-05-20 | 2025-05-15 | 4 | Bolte Axel | INZY | Common Stock | D | 0,9800 | 4.407 | 4 | 423.926 | ||||
| 2025-05-20 | 2025-05-15 | 4 | Bolte Axel | INZY | Common Stock | D | 0,9800 | 152.823 | 150 | 419.519 | ||||
| 2025-04-03 | 2025-04-02 | 4 | Treco Douglas A | INZY | Common Stock | D | 0,8900 | -8.819 | -8 | 41.046 | ||||
| 2025-04-03 | 2025-04-01 | 4 | Treco Douglas A | INZY | Common Stock | D | 25.000 | 49.865 | ||||||
| 2025-04-02 | 2025-03-31 | 4 | Winton Matthew | INZY | Common Stock | D | 0,7700 | 2.490 | 2 | 7.388 | ||||
| 2025-04-02 | 2025-03-31 | 4 | Subramanian Sanjay | INZY | Common Stock | D | 0,7700 | 2.490 | 2 | 32.888 | ||||
| 2024-10-03 | 2024-09-30 | 4 | Treco Douglas A | INZY | Common Stock | D | 4,4500 | 1.710 | 8 | 22.375 | ||||
| 2024-10-03 | 2024-09-30 | 4 | Winton Matthew | INZY | Common Stock | D | 4,4500 | 1.710 | 8 | 4.898 | ||||
| 2024-04-03 | 2024-03-28 | 4 | Winton Matthew | INZY | Common Stock | D | 3,3300 | 3.188 | 11 | 3.188 | ||||
| 2024-04-03 | 2024-04-02 | 4 | Treco Douglas A | INZY | Common Stock | D | 6,9400 | -7.523 | -52 | 20.665 | ||||
| 2024-04-03 | 2024-04-01 | 4 | Treco Douglas A | INZY | Common Stock | D | 25.000 | 28.188 | ||||||
| 2023-10-03 | 2023-09-29 | 4 | Subramanian Sanjay | INZY | Common Stock | D | 3,5700 | 2.319 | 8 | 30.398 | ||||
| 2023-08-03 | 2023-08-01 | 4 | Pivotal bioVenture Partners Fund I, L.P. See footnotes | INZY | Common Stock | I | 4,8000 | 714.285 | 3.429 | 1.571.741 | ||||
| 2023-08-03 | 2023-08-01 | 4 | Pivotal bioVenture Partners Fund I, L.P. See footnotes | INZY | Common Stock | I | 4,8000 | 119.048 | 571 | 2.923.110 | ||||
| 2023-08-03 | 2023-08-01 | 4 | Hopfner Robert Lorne By Pivotal | INZY | Common Stock | I | 4,8000 | 714.285 | 3.429 | 1.571.741 | ||||
| 2023-08-03 | 2023-08-01 | 4 | Hopfner Robert Lorne By Pivotal | INZY | Common Stock | I | 4,8000 | 119.048 | 571 | 2.923.110 | ||||
| 2023-05-15 | 2023-05-12 | 4 | Hopfner Robert Lorne By Pivotal | INZY | Common Stock | I | 6,2500 | 228.702 | 1.429 | 3.661.518 | ||||
| 2023-05-15 | 2023-05-11 | 4 | Hopfner Robert Lorne By Pivotal | INZY | Common Stock | I | 6,4800 | 219.230 | 1.421 | 3.432.816 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Bolte Axel | INZY | Common Stock | D | 2,2100 | 4.806 | 11 | 266.696 | ||||
| 2023-04-04 | 2023-03-31 | 4 | Subramanian Sanjay | INZY | Common Stock | D | 2,2100 | 979 | 2 | 28.079 | ||||
| 2023-03-30 | 2023-03-29 | 4 | Hopfner Robert Lorne See footnotes | INZY | Common Stock | I | 4,5379 | 344.592 | 1.564 | 3.213.586 | ||||
| 2023-03-29 | 2023-03-28 | 4 | Hopfner Robert Lorne See footnotes | INZY | Common Stock | I | 4,1612 | 156.766 | 652 | 2.868.994 | ||||
| 2023-03-29 | 2023-03-27 | 4 | Hopfner Robert Lorne See footnotes | INZY | Common Stock | I | 3,6952 | 51.074 | 189 | 2.712.228 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Bjarke Henric Bjorn | INZY | Common Stock | D | 1,3900 | 21.500 | 30 | 105.441 | ||||
| 2022-10-04 | 2022-09-30 | 4 | Bolte Axel | INZY | Common Stock | D | 2,2800 | 3.315 | 8 | 261.890 | ||||
| 2022-10-04 | 2022-09-30 | 4 | Bjarke Henric Bjorn | INZY | Common Stock | D | 2,2800 | 3.315 | 8 | 83.941 | ||||
| 2022-04-21 | 2022-04-19 | 4 | Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. | INZY | Common Stock | I | 3,6900 | 1.355.000 | 5.000 | 4.174.379 | ||||
| 2022-04-20 | 2022-04-19 | 4 | Pivotal bioVenture Partners Fund I, L.P. See footnotes | INZY | Common Stock | I | 3,6900 | 1.070.000 | 3.948 | 2.661.154 | ||||
| 2022-04-20 | 2022-04-19 | 4 | Bjarke Henric Bjorn | INZY | Common Stock | D | 3,6900 | 27.100 | 100 | 80.626 | ||||
| 2022-04-20 | 2022-04-19 | 4 | Hopfner Robert Lorne By Pivotal bioVenture Partners Fund I, L.P. | INZY | Common Stock | I | 3,6900 | 1.070.000 | 3.948 | 2.661.154 | ||||
| 2022-04-20 | 2022-04-19 | 4 | Subramanian Sanjay | INZY | Common Stock | D | 3,6900 | 27.100 | 100 | 27.100 | ||||
| 2022-04-20 | 2022-04-19 | 4 | Bolte Axel | INZY | Common Stock | D | 3,6900 | 67.750 | 250 | 258.575 | ||||
| 2022-03-22 | 2022-03-21 | 4 | Subramanian Sanjay | INZY | Stock option (right to buy) | D | 3,96 | 180.000 | 180.000 | |||||
| 2022-02-28 | 2022-02-24 | 4 | Bolte Axel | INZY | Stock option (right to buy) | D | 5,78 | 275.000 | 275.000 | |||||
| 2022-02-28 | 2022-02-24 | 4 | Bjarke Henric Bjorn | INZY | Stock option (right to buy) | D | 5,78 | 115.000 | 115.000 | |||||
| 2021-06-25 | 2021-06-24 | 4 | Bolte Axel | INZY | Stock Option (right to buy) | D | 0,98 | -66.788 | 100.480 | |||||
| 2021-06-25 | 2021-06-24 | 4 | Bolte Axel | INZY | Common Stock | D | 0,0001 | -66.788 | -0 | 190.825 | ||||
| 2021-06-25 | 2021-06-24 | 4 | Bolte Axel | INZY | Common Stock | D | 0,9800 | 66.788 | 65 | 257.613 | ||||
| 2021-06-25 | 2021-06-23 | 4 | Bhagat Sarah M | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-06-24 | 2021-06-23 | 4 | Mathers Edward T | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-06-24 | 2021-06-23 | 4 | Edwards Martin | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-06-24 | 2021-06-23 | 4 | Treco Douglas A | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-06-24 | 2021-06-23 | 4 | Sullivan Lynne Marie | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-06-24 | 2021-06-23 | 4 | Hopfner Robert Lorne | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-06-24 | 2021-06-23 | 4 | DIAZ REINALDO M | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-06-24 | 2021-06-23 | 4 | Inozyme Pharma, Inc. | INZY | Stock Option (right to buy) | D | 17,12 | 9.367 | 9.367 | |||||
| 2021-05-18 | 2021-05-17 | 4 | DiPalma Stephen J. | INZY | Stock option (Right to Buy) | D | 15,90 | 15.000 | 15.000 | |||||
| 2021-03-25 | 2021-03-24 | 4 | Basso Stephen | INZY | Stock Option (right to buy) | D | 17,77 | 13.000 | 13.000 | |||||
| 2021-03-17 | 2021-03-04 | 4 | Jungles Steven J | INZY | Stock Option (right to buy) | D | 19,78 | 42.000 | 42.000 | |||||
| 2021-03-17 | 2021-03-04 | 4 | Bolte Axel | INZY | Stock option (right to buy) | D | 19,78 | 117.000 | 117.000 | |||||
| 2021-03-17 | 2021-03-04 | 4 | Basso Stephen | INZY | Stock Option (right to buy) | D | 19,78 | 27.000 | 27.000 | |||||
| 2021-03-17 | 2021-03-04 | 4 | Bjarke Henric Bjorn | INZY | Stock option (right to buy) | D | 19,78 | 51.000 | 51.000 | |||||
| 2021-02-04 | 2021-02-02 | 4 | Wenkert Deborah | INZY | Stock option (Right to Buy) | D | 22,61 | 100.000 | 100.000 | |||||
| 2021-02-01 | 2021-01-28 | 4 | Novo A/S | INZY | COMMON STOCK | D | 21,0000 | -375.000 | -7.875 | 2.194.379 | ||||
| 2021-01-14 | 2021-01-13 | 4 | Jungles Steven J | INZY | Stock Option (right to buy) | D | 2,77 | 44.315 | 44.315 | |||||
| 2021-01-14 | 2021-01-13 | 4 | Huertas Pedro | INZY | Stock Option (Right to buy) | D | 2,77 | 36.074 | 36.074 | |||||
| 2021-01-14 | 2021-01-13 | 4 | Bjarke Henric Bjorn | INZY | Stock Option (right to buy) | D | 2,77 | 51.105 | 51.105 | |||||
| 2021-01-14 | 2021-01-13 | 4 | Basso Stephen | INZY | Stock Option (right to buy) | D | 2,77 | 41.794 | 41.794 | |||||
| 2021-01-14 | 2021-01-13 | 4 | Bolte Axel | INZY | Stock option (right to buy) | D | 16,00 | 66.788 | 66.788 | |||||
| 2021-01-14 | 2021-01-13 | 4 | Bolte Axel | INZY | Stock Option (right to buy) | D | 2,77 | 159.187 | 159.187 | |||||
| 2020-07-29 | 2020-07-28 | 4 | Novo A/S | INZY | SERIES A-2 CONVERTIBLE PREFERRED STOCK | D | -1.398.600 | 0 | ||||||
| 2020-07-29 | 2020-07-28 | 4 | Novo A/S | INZY | SERIES A CONVERTIBLE PREFERRED STOCK | D | -15.000.000 | 0 | ||||||
| 2020-07-29 | 2020-07-28 | 4 | Novo A/S | INZY | COMMON STOCK | D | 16,0000 | 375.000 | 6.000 | 2.569.379 | ||||
| 2020-07-29 | 2020-07-28 | 4 | Novo A/S | INZY | COMMON STOCK | D | 2.194.379 | 2.194.379 | ||||||
| 2020-07-29 | 2020-07-28 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc. | INZY | Series A Convertible Preferred Stock (par value, $0.0001) | I | 0,00 | -3.279.720 | 0 | |||||
| 2020-07-29 | 2020-07-28 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc. | INZY | Common Stock (par value $0.0001) | I | 16,0000 | 81.250 | 1.300 | 520.125 | ||||
| 2020-07-29 | 2020-07-28 | 4 | Sanofi Through its wholly-owned subsidiary, Aventis Inc. | INZY | Common Stock (par value $0.0001) | I | 438.875 | 438.875 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Rock Springs Capital Management LP | INZY | Series A-2 Convertible Preferred Stock | I | -3.496.504 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Rock Springs Capital Management LP | INZY | Common Stock | I | 16,0000 | 24.000 | 384 | 1.067.884 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Rock Springs Capital Management LP | INZY | Common Stock | I | 16,0000 | 576.000 | 9.216 | 1.043.884 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Rock Springs Capital Management LP | INZY | Common Stock | I | 467.884 | 467.884 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | INZY | Series A-2 Convertible Preferred Stock | I | -10.489.510 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | INZY | Common Stock | I | 16,0000 | 187.500 | 3.000 | 1.591.154 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Pivotal bioVenture Partners Fund I, L.P. | INZY | Common Stock | I | 1.403.654 | 1.403.654 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Jungles Steven J By Steven Jungles Trust Dated Nov. 12, 2014 | INZY | Series A Convertible Preferred Stock | I | -100.000 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Jungles Steven J By Steven Jungles Trust Dated Nov. 12, 2014 | INZY | Common Stock | I | 13.381 | 55.417 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. | INZY | Series A-2 Convertible Preferred Stock | I | -1.398.600 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. | INZY | Series A Convertible Preferred Stock | I | -15.000.000 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. | INZY | Common Stock | I | 16,0000 | 625.000 | 10.000 | 2.819.379 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. | INZY | Common Stock | I | 187.154 | 2.194.379 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Longitude Capital Partners III, LLC By Longitude Venture Partners III, L.P. | INZY | Common Stock | I | 2.007.225 | 2.007.225 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | New Enterprise Associates 15, L.P. | INZY | Series A-2 Preferred Stock | D | -187.156 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | New Enterprise Associates 15, L.P. | INZY | Series A Preferred Stock | D | -2.000.533 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | New Enterprise Associates 15, L.P. | INZY | Common Stock | D | 16,0000 | 250.000 | 4.000 | 2.437.689 | ||||
| 2020-07-28 | 2020-07-28 | 4 | New Enterprise Associates 15, L.P. | INZY | Common Stock | D | 187.156 | 2.187.689 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | New Enterprise Associates 15, L.P. | INZY | Common Stock | D | 2.000.533 | 2.000.533 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | BASKETT FOREST See Note 2 | INZY | Common Stock | I | 16,0000 | 250.000 | 4.000 | 2.437.689 | ||||
| 2020-07-28 | 2020-07-28 | 4 | BASKETT FOREST See Note 2 | INZY | Common Stock | I | 187.156 | 2.187.689 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | BASKETT FOREST See Note 2 | INZY | Common Stock | I | 2.000.533 | 2.000.533 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | BASKETT FOREST See Note 2 | INZY | Series A-2 Preferred Stock | I | -187.156 | 0 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | BASKETT FOREST See Note 2 | INZY | Series A Preferred Stock | I | -2.000.533 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Florence Anthony A. Jr. See Note 2 | INZY | Common Stock | I | 16,0000 | 250.000 | 4.000 | 2.437.689 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Florence Anthony A. Jr. See Note 2 | INZY | Common Stock | I | 187.156 | 2.187.689 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Florence Anthony A. Jr. See Note 2 | INZY | Common Stock | I | 2.000.533 | 2.000.533 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | Florence Anthony A. Jr. See Note 2 | INZY | Series A-2 Preferred Stock | I | -187.156 | 0 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | Florence Anthony A. Jr. See Note 2 | INZY | Series A Preferred Stock | I | -2.000.533 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Makhzoumi Mohamad See Note 2 | INZY | Common Stock | I | 16,0000 | 250.000 | 4.000 | 2.437.689 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Makhzoumi Mohamad See Note 2 | INZY | Common Stock | I | 187.156 | 2.187.689 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Makhzoumi Mohamad See Note 2 | INZY | Common Stock | I | 2.000.533 | 2.000.533 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | Makhzoumi Mohamad See Note 2 | INZY | Series A-2 Preferred Stock | I | -187.156 | 0 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | Makhzoumi Mohamad See Note 2 | INZY | Series A Preferred Stock | I | -2.000.533 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | MAKOWER JOSHUA See Note 2 | INZY | Common Stock | I | 16,0000 | 250.000 | 4.000 | 2.437.689 | ||||
| 2020-07-28 | 2020-07-28 | 4 | MAKOWER JOSHUA See Note 2 | INZY | Common Stock | I | 187.156 | 2.187.689 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | MAKOWER JOSHUA See Note 2 | INZY | Common Stock | I | 2.000.533 | 2.000.533 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | MAKOWER JOSHUA See Note 2 | INZY | Series A-2 Preferred Stock | I | -187.156 | 0 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | MAKOWER JOSHUA See Note 2 | INZY | Series A Preferred Stock | I | -2.000.533 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | SANDELL SCOTT D See Note 2 | INZY | Common Stock | I | 16,0000 | 250.000 | 4.000 | 2.437.689 | ||||
| 2020-07-28 | 2020-07-28 | 4 | SANDELL SCOTT D See Note 2 | INZY | Common Stock | I | 187.156 | 2.187.689 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | SANDELL SCOTT D See Note 2 | INZY | Common Stock | I | 2.000.533 | 2.000.533 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | SANDELL SCOTT D See Note 2 | INZY | Series A-2 Preferred Stock | I | -187.156 | 0 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | SANDELL SCOTT D See Note 2 | INZY | Series A Preferred Stock | I | -2.000.533 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Sonsini Peter W. See Note 2 | INZY | Common Stock | I | 16,0000 | 250.000 | 4.000 | 2.437.689 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Sonsini Peter W. See Note 2 | INZY | Common Stock | I | 187.156 | 2.187.689 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Sonsini Peter W. See Note 2 | INZY | Common Stock | I | 2.000.533 | 2.000.533 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | Sonsini Peter W. See Note 2 | INZY | Series A-2 Preferred Stock | I | -187.156 | 0 | ||||||
| 2020-07-28 | 2020-07-25 | 4 | Sonsini Peter W. See Note 2 | INZY | Series A Preferred Stock | I | -2.000.533 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | RA CAPITAL MANAGEMENT, LLC | INZY | Series A-2 Convertible Preferred Stock | I | -10.489.510 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | RA CAPITAL MANAGEMENT, LLC | INZY | Common Stock | I | 16,0000 | 600.000 | 9.600 | 2.003.653 | ||||
| 2020-07-28 | 2020-07-28 | 4 | RA CAPITAL MANAGEMENT, LLC | INZY | Common Stock | I | 1.403.653 | 1.403.653 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Sofinnova Venture Partners X, L.P. | INZY | Series A-2 Convertible Preferred Stock | D | -11.888.112 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Sofinnova Venture Partners X, L.P. | INZY | Common Stock | D | 16,0000 | 437.500 | 7.000 | 2.028.308 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Sofinnova Venture Partners X, L.P. | INZY | Common Stock | D | 1.590.808 | 1.590.808 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | ALEXION PHARMACEUTICALS INC | INZY | Series A-2 Convertible Preferred Stock | D | -8.294.360 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | ALEXION PHARMACEUTICALS INC | INZY | Common Stock | D | 1.109.910 | 1.109.910 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Hopfner Robert Lorne By Pivotal bioVenture Partners Fund I, L.P. | INZY | Series A-2 Convertible Preferred Stock | I | -10.489.510 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Hopfner Robert Lorne By Pivotal bioVenture Partners Fund I, L.P. | INZY | Common Stock | I | 16,0000 | 187.500 | 3.000 | 1.591.154 | ||||
| 2020-07-28 | 2020-07-28 | 4 | Hopfner Robert Lorne By Pivotal bioVenture Partners Fund I, L.P. | INZY | Common Stock | I | 1.403.654 | 1.403.654 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Schlessinger Joseph | INZY | Series A Convertible Preferred Stock | D | -100.000 | 0 | ||||||
| 2020-07-28 | 2020-07-28 | 4 | Schlessinger Joseph | INZY | Common Stock | D | 13.381 | 286.479 | ||||||
| 2020-07-24 | 2020-07-23 | 4 | Mathers Edward T | INZY | Stock Option (right to buy) | D | 16,00 | 9.367 | 9.367 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Edwards Martin | INZY | Stock Option (right to buy) | D | 16,00 | 9.367 | 9.367 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Treco Douglas A | INZY | Stock Option (right to buy) | D | 16,00 | 9.367 | 9.367 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Huertas Pedro | INZY | Stock Option (right to buy) | D | 16,00 | 43.951 | 43.951 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Sullivan Lynne Marie | INZY | Stock Option (right to buy) | D | 16,00 | 9.367 | 9.367 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Bjarke Henric Bjorn | INZY | Stock Option (right to buy) | D | 16,00 | 32.905 | 32.905 | |||||
| 2020-07-24 | 2020-07-23 | 4 | DIAZ REINALDO M | INZY | Stock Option (right to buy) | D | 16,00 | 9.367 | 9.367 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Hopfner Robert Lorne | INZY | Stock Option (right to buy) | D | 16,00 | 9.367 | 9.367 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Bolte Axel | INZY | Stock Option (right to buy) | D | 16,00 | 287.706 | 287.706 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Bhagat Sarah M | INZY | Stock Option (right to buy) | D | 16,00 | 9.367 | 9.367 | |||||
| 2020-07-24 | 2020-07-23 | 4 | Basso Stephen | INZY | Stock Option (right to buy) | D | 16,00 | 27.433 | 27.433 | |||||
| 2020-07-23 | 3 | Jungles Steven J By Steven Jungles Trust Dated Nov. 12, 2014 | INZY | Common Stock | I | 84.072 | ||||||||
| 2020-07-23 | 3 | Jungles Steven J By Steven Jungles Trust Dated Nov. 12, 2014 | INZY | Common Stock | I | 84.072 | ||||||||
| 2020-07-23 | 3 | Jungles Steven J By Steven Jungles Trust Dated Nov. 12, 2014 | INZY | Common Stock | I | 84.072 | ||||||||
| 2020-07-23 | 3 | Schlessinger Joseph | INZY | Common Stock | D | 546.196 | ||||||||
| 2020-07-23 | 3 | Schlessinger Joseph | INZY | Common Stock | D | 546.196 | ||||||||
| 2020-07-23 | 3 | Schlessinger Joseph | INZY | Common Stock | D | 546.196 | ||||||||
| 2020-07-23 | 3 | Bolte Axel | INZY | Common Stock | D | 381.650 | ||||||||
| 2020-07-23 | 3 | Bolte Axel | INZY | Common Stock | D | 381.650 | ||||||||
| 2020-07-23 | 3 | Bolte Axel | INZY | Common Stock | D | 381.650 | ||||||||
| 2020-07-23 | 3 | Bjarke Henric Bjorn | INZY | Common Stock | D | 107.052 | ||||||||
| 2020-07-23 | 3 | Bjarke Henric Bjorn | INZY | Common Stock | D | 107.052 | ||||||||
| 2020-07-23 | 3 | Bjarke Henric Bjorn | INZY | Common Stock | D | 107.052 | ||||||||
| 2020-07-23 | 3 | Braddock Demetrios | INZY | Common Stock | D | 763.300 | ||||||||
| 2020-07-23 | 3 | Braddock Demetrios | INZY | Common Stock | D | 763.300 | ||||||||
| 2020-07-23 | 3 | Braddock Demetrios | INZY | Common Stock | D | 763.300 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
